Biodesix, Inc. (BDSX) Dividend History

Biodesix, Inc. is a molecular diagnostics company specializing in blood-based tests for lung disease, including lung cancer and infectious diseases. The company develops and commercializes liquid biopsy tests to aid in early detection, diagnosis, and treatment monitoring, leveraging advanced proteomic and genomic technologies to improve patient outcomes.

919 West Dillon Road, Louisville, CO, 80027
Phone: 303-417-0500
Website: https://www.biodesix.com

Dividend History

Biodesix, Inc. currently does not pay dividends

Company News

  • Biodesix, a diagnostic solutions company, announced that new data from two studies will be presented at upcoming conferences. The studies highlight challenges in managing lung nodules and the potential of Biodesix's tests to guide clinical decision-making.

    GlobeNewswire Inc.
  • Tap five stocks with increasing P/E ratios to try out a different approach. These stocks include CLEAR Secure (YOU), Applied DNA Sciences (APDN), Phreesia (PHR), Vigil Neuroscience (VIGL) and Biodesix (BDSX).

    Zacks Investment Research
    Featured Companies: APDN PHR VIGL YOU
  • U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Friday. The Dow traded up 0.89% to 38,941.18 while the NASDAQ rose 1.26% to 16,251.98. The S&P 500 also rose, gaining, 1.10% to 5,203.90. Check This Out: Top 3 Materials Stocks That May Explode This Quarter   Leading and Lagging Sectors   Communication services shares jumped by 1.8% on Friday. In trading on Friday, utilities shares rose by just 0.2%.   Top Headline   U.S. employers added 303,000 nonfarm payrolls in March, marking an increase from the 270,000 reading in February and surpassing the expected 212,000, the Bureau of Labor Statistics said Friday. The unemployment rate slowed from 3.9% to 3.8%, easing more than expected.   Equities Trading UP   MediaCo Holding Inc. (NASDAQ: MDIA) shares shot up 190% to $4.0550 after a 13D amended filing showed Standard General L.P. reported a 95.2% stake in the company as of April 1, 2024. Shares of GCT Semiconductor Holding, Inc. (NASDAQ: GCTS) got a boost, surging 52% to $8.72 after the company and Aramco signed an MOU to accelerate the development of the 4G and 5G ecosystem in Saudi Arabia. HUB ...

    Benzinga
    Featured Companies: GCTS HUBC MDIA ZGN
  • The company's diagnostic tests may obtain better coverage from the Centers for Medicare & Medicaid Services.

    The Motley Fool
    Featured Companies: CDNA
Page data last updated 07/22/2025 19:02:54 UTC